Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
486.92
342.92
1,014.46
631.66
611.83
374.65
764.42
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
486.92
342.92
1,014.46
631.66
611.83
374.65
764.42
Raw Material Cost
343.72
234.04
680.32
361.80
332.68
205.22
424.07
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
6.20
4.92
5.39
5.76
3.51
3.53
2.99
Selling and Distribution Expenses
70.13
74.47
122.90
123.54
106.42
63.92
108.82
Other Expenses
-0.31
0.25
1.72
0.39
0.26
0.40
0.40
Total Expenditure (Excl Depreciation)
417.00
315.90
825.79
495.02
445.15
276.65
539.91
Operating Profit (PBDIT) excl Other Income
69.9
27
188.70000000000002
136.6
166.70000000000002
98
224.5
Other Income
11.57
14.12
6.43
12.23
12.43
15.42
2.60
Operating Profit (PBDIT)
120.14
79.90
128.75
183.44
208.54
144.84
252.95
Interest
6.20
4.92
5.39
5.76
3.51
3.53
2.99
Exceptional Items
0.80
-0.98
10.10
0.42
-3.87
-2.36
16.97
Gross Profit (PBDT)
143.20
108.88
334.14
269.86
279.15
169.43
340.35
Depreciation
44.93
44.93
40.09
40.09
35.60
35.60
33.70
Profit Before Tax
69.80
29.08
93.36
138.01
165.57
103.36
233.23
Tax
7.56
6.34
31.33
16.43
18.59
14.42
30.95
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
61.33
22.97
62.09
121.39
146.70
89.09
202.59
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
61.33
22.97
62.09
121.39
146.70
89.09
202.59
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.91
-0.24
-0.05
0.19
0.27
-0.15
-0.30
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
62.24
22.73
62.04
121.58
146.98
88.94
202.28
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
8,056.25
8,110.99
8,088.03
8,025.95
7,904.56
8,013.74
7,924.65
Earnings per share (EPS)
0.07
0.02
0.07
0.13
0.15
0.09
0.21
Diluted Earnings per share
0.07
0.02
0.07
0.13
0.15
0.09
0.21
Operating Profit Margin (Excl OI)
13.07%
6.08%
8.11%
20.76%
26.23%
25.04%
28.34%
Gross Profit Margin
23.56%
21.58%
13.16%
28.19%
32.88%
37.09%
34.92%
PAT Margin
12.6%
6.7%
6.12%
19.22%
23.98%
23.78%
26.5%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is -20.42% vs -12.05% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is -57.69% vs -28.33% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is -44.62% vs -21.28% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is 77.14% vs 0.00% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
Compare Quarterly Results Of Pacific Shuanglin Bio-pharmacy Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
486.92
0
486.92
Other Operating Income
0.00
0.00
0.00
Total Operating income
486.92
0
486.92
Raw Material Cost
343.72
0
343.72
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
6.20
0
6.20
Selling and Distribution Expenses
70.13
0
70.13
Other Expenses
-0.31
0.00
-0.31
Total Expenditure (Excl Depreciation)
417.00
0
417.00
Operating Profit (PBDIT) excl Other Income
69.93
0.00
69.93
Other Income
11.57
0
11.57
Operating Profit (PBDIT)
120.14
0
120.14
Interest
6.20
0
6.20
Exceptional Items
0.80
0
0.80
Gross Profit (PBDT)
143.20
0
143.20
Depreciation
44.93
0
44.93
Profit Before Tax
69.80
0
69.80
Tax
7.56
0
7.56
Provisions and contingencies
0
0
0.00
Profit After Tax
61.33
0
61.33
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
61.33
0
61.33
Share in Profit of Associates
0
0
0.00
Minority Interest
0.91
0
0.91
Other related items
0.00
0.00
0.00
Consolidated Net Profit
62.24
0
62.24
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
8,056.25
0
8,056.25
Earnings per share (EPS)
0.07
0
0.07
Diluted Earnings per share
0.07
0
0.07
Operating Profit Margin (Excl OI)
13.07%
0%
0.00
13.07%
Gross Profit Margin
23.56%
0%
0.00
23.56%
PAT Margin
12.60%
0%
0.00
12.60%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 48.69 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 41.99% vs -66.20% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -20.42% vs -12.05% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 6.22 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 174.01% vs -63.39% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -57.69% vs -28.33% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.86 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 65.05% vs -46.20% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -44.62% vs -21.28% in Jun 2025
Quarterly - Interest
Interest 0.62 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 26.53% vs -9.26% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 77.14% vs 0.00% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.07%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
Footer loading
